Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Vetter breaks ground on $285m clinical site in Illinois to expand early-phase manufacturing Vetter begins construction on a new $285M clinical manufacturing site in Illinois to boost early-phase injectable drug development. Completion slated for 2029. byPallavi MadhirajuJune 29, 2025